{"id":2543,"date":"2018-04-25T02:51:32","date_gmt":"2018-04-25T02:51:32","guid":{"rendered":"http:\/\/asadkarim.co.uk\/?p=2543"},"modified":"2018-04-12T08:52:53","modified_gmt":"2018-04-12T08:52:53","slug":"glaxo-smithkline-april-dividend","status":"publish","type":"post","link":"https:\/\/www.asadkarim.co.uk\/?p=2543","title":{"rendered":"Glaxo Smithkline April dividend."},"content":{"rendered":"<p>On Thur 12th April, the UK&#8217;s premier health and pharma company, Glaxo Smithkline paid its half yearly dividend.<\/p>\n<p><a href=\"http:\/\/www.gsk.com\" target=\"_blank\">www.gsk.com<\/a><\/p>\n<p>12p per share.<\/p>\n<p><a href=\"https:\/\/otp.investis.com\/clients\/uk\/GlaxoSmithKline2\/rns_new\/regulatory-story.aspx?cid=410&amp;newsid=995740\" target=\"_blank\">https:\/\/otp.investis.com\/clients\/uk\/GlaxoSmithKline2\/rns_new\/regulatory-story.aspx?cid=410&amp;newsid=995740<\/a><\/p>\n<p>the total number of voting rights in the Company is 4,958,962,323<\/p>\n<p>Thus:<\/p>\n<p>23p x 4,958,962,323 = \u00a31,140,561,334.29<\/p>\n<p>That is <strong>\u00a31.14 Billion<\/strong><\/p>\n<p><a href=\"http:\/\/www.shareshop.hsbc.co.uk\/shareshop\/security.cgi?csi=10042\" target=\"_blank\">http:\/\/www.shareshop.hsbc.co.uk\/shareshop\/security.cgi?csi=10042<\/a><\/p>\n<p>5.5% yield.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On Thur 12th April, the UK&#8217;s premier health and pharma company, Glaxo Smithkline paid its half yearly dividend. www.gsk.com 12p per share. https:\/\/otp.investis.com\/clients\/uk\/GlaxoSmithKline2\/rns_new\/regulatory-story.aspx?cid=410&amp;newsid=995740 the total number of voting rights in the Company is 4,958,962,323 Thus: 23p x 4,958,962,323 = \u00a31,140,561,334.29 That is \u00a31.14 Billion http:\/\/www.shareshop.hsbc.co.uk\/shareshop\/security.cgi?csi=10042 5.5% yield.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2543","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/2543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2543"}],"version-history":[{"count":1,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/2543\/revisions"}],"predecessor-version":[{"id":2544,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/2543\/revisions\/2544"}],"wp:attachment":[{"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2543"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2543"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.asadkarim.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}